Evidence map›Paper›PMID 24205416›Full record

ArticlePLoS neglected tropical diseases2013

On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.

Leonardo P Farias, Greice Krautz-Peterson, Cibele A Tararam, Bogar O Araujo-Montoya, Tatiana R Fraga, Henrique K Rofatto, Floriano P Silva, Lourdes Isaac, Akram A Da'dara, R Alan Wilson and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Anti-schistosomal immunity to core xylose/fucose in N-glycans.Frontiers in molecular biosciences · 2023
    Article
  4. Article
  5. Molecular omics · 2022
    Article
  6. Article
  7. Schistosome immunomodulators.PLoS pathogens · 2021
    Review
  8. Article
  9. Systematic screening of 96Wellcome open research · 2019
    Article
  10. Review
  11. Article
  12. Article
  13. How schistosomes alter the human serum proteome.Molecular and biochemical parasitology · 2017
    Article
  14. International journal of clinical and experimental pathology · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Transfection of Platyhelminthes.BioMed research international · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Leonardo P FariasCentro de Biotecnologia, Instituto Butantan, São Paulo, Brazil.
Greice Krautz-Peterson
Cibele A Tararam
Bogar O Araujo-Montoya
Tatiana R Fraga
Henrique K Rofatto
Floriano P Silva
Lourdes Isaac
Akram A Da'dara
R Alan Wilson
Charles B Shoemaker
Luciana C C Leite
Instituto Butantan · BRTufts University · USUniversidade de São Paulo · BRFundação Oswaldo Cruz · BRUniversity of York · GB

Funding

Gene silencing in schistosomes using RNAiR01AI056273 · NIAID · TUFTS UNIVERSITY BOSTON · PI Patrick J Skelly · 2004 to 2026
$7.2M
RNAi-based functional analysis of schistosome CD59-like as complement regulatorsR03AI095893 · NIAID · TUFTS UNIVERSITY BOSTON · PI KRAUTZ-PETERSON, GREICE · 2012 to 2013
$165k
NIAID NIH HHS AI-056273NIAID NIH HHS AI-095893NIAID NIH HHS R01 AI056273NIAID NIH HHS R03 AI095893
6 · The paper itself

Abstract

backgroundIt is believed that schistosomes evade complement-mediated killing by expressing regulatory proteins on their surface. Recently, six homologues of human CD59, an important inhibitor of the complement system membrane attack complex, were identified in the schistosome genome. Therefore, it is important to investigate whether these molecules could act as CD59-like complement inhibitors in schistosomes as part of an immune evasion strategy. METHODOLOGY/PRINCIPAL

findingsHerein, we describe the molecular characterization of seven putative SmCD59-like genes and attempt to address the putative biological function of two isoforms. Superimposition analysis of the 3D structure of hCD59 and schistosome sequences revealed that they contain the three-fingered protein domain (TFPD). However, the conserved amino acid residues involved in complement recognition in mammals could not be identified. Real-time RT-PCR and Western blot analysis determined that most of these genes are up-regulated in the transition from free-living cercaria to adult worm stage. Immunolocalization experiments and tegument preparations confirm that at least some of the SmCD59-like proteins are surface-localized; however, significant expression was also detected in internal tissues of adult worms. Finally, the involvement of two SmCD59 proteins in complement inhibition was evaluated by three different approaches: (i) a hemolytic assay using recombinant soluble forms expressed in Pichia pastoris and E. coli; (ii) complement-resistance of CHO cells expressing the respective membrane-anchored proteins; and (iii) the complement killing of schistosomula after gene suppression by RNAi. Our data indicated that these proteins are not involved in the regulation of complement activation.

conclusionsOur results suggest that this group of proteins belongs to the TFPD superfamily. Their expression is associated to intra-host stages, present in the tegument surface, and also in intra-parasite tissues. Three distinct approaches using SmCD59 proteins to inhibit complement strongly suggested that these proteins are not complement inhibitors and their function in schistosomes remains to be determined.

Indexed as

Host-Pathogen InteractionsImmune EvasionAnimalsComplement System ProteinsCricetinaeFemaleHelminth ProteinsHumansMaleMembrane ProteinsModels, MolecularProtein ConformationSchistosoma mansoniComplement System ProteinsHelminth ProteinsMembrane Proteins

Identifiers

PMID24205416
PMCPMC3812095
OpenAlexW2004283579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.